Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Recurrence 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1Anophthalmia with pulmonary hypoplasia 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × epitumomab × Clear all
NCT02132403 2015-05-01

PM-01

University of Illinois at Chicago

Phase 1 Terminated
3 enrolled
Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

NCT00770354 2009-08-10

Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer

Antisoma Research

Phase 2 Terminated
110 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡